Differential response to resistance training in CHF according to ACE genotype

International Journal of Cardiology

Volumn 149, Issue 3, 2011, Pages 330-334

  Williams, Andrew D ^a   Anderson, Mitchell J ^b   Selig, Steve ^c   Carey, Michael F ^c   Febbraio, Mark A ^d   Hayes, Alan ^c   Toia, Deidre ^b   Harrap, Stephen B ^b   Hare, David L ^b  

^a UNIVERSITY OF TASMANIA   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c VICTORIA UNIVERSITY   (Australia)

^d BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

Author keywords

Exercise; Genes; Heart failure

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE; LACTIC ACID;

ADULT; ARTICLE; BLOOD SAMPLING; BODY MASS; CLINICAL ARTICLE; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; EXERCISE TEST; EXERCISE TOLERANCE; FEMALE; GENE FREQUENCY; GENOTYPE; HEART EJECTION FRACTION; HEART FAILURE; HEART MUSCLE OXYGEN CONSUMPTION; HOMOZYGOSITY; HUMAN; ISCHEMIC CARDIOMYOPATHY; MALE; MUSCLE EXERCISE; MUSCLE STRENGTH; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RESISTANCE TRAINING;

AGED; CHRONIC DISEASE; FEMALE; GENOTYPE; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; OXYGEN CONSUMPTION; PEPTIDYL-DIPEPTIDASE A; PHYSICAL ENDURANCE; RESISTANCE TRAINING; SEVERITY OF ILLNESS INDEX;

EID: 79958088796     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2010.02.012     Document Type: Article

References (31)

1. Rigat B, Hubert C, Corvol P, Soubrier F. PCR detection of the insertion/deletion polymorphism of the human angiotensin converting enzyme gene (DCP1) (dipeptidyl carboxypeptidase 1). Nucleic Acids Res 1992;20:1433.
2. Cambien F, Poirier O, Lecerf L, et al. Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature 1992;359:641-4.
3. Ruiz J, Blanche H, Cohen N, et al. Insertion/deletion polymorphism of the angiotensin-converting enzyme gene is strongly associated with coronary heart disease in non-insulin-dependent diabetes mellitus. Proc Natl Acad Sci U S A 1994;91:3662-5. (Pubitemid 24139491)
4. Yoshida M, Iwai N, Ohmichi N, et al. D allele of the angiotensin- converting enzyme gene is a risk factor for secondary cardiac events after myocardial infarction. Int J Cardiol 1999;70:119-25. (Pubitemid 29354361)
5. Huang W, Xie C, Zhou H, Yang T, Sun M. Association of the angiotensin-converting enzyme gene polymorphism with chronic heart failure in Chinese Han patients. Eur J Heart Fail 2004;6:23-7. (Pubitemid 38169601)
6. Clark AL, Poole-Wilson PA, Coats AJS. Exercise limitation in chronic heart failure: central role of the periphery. J Am Coll Cardiol 1996;28:1092-102. (Pubitemid 26376979)
7. Bittner V, Weiner DH, Yusuf S, et al. Prediction of mortality and morbidity with a 6-minute walk test in patients with left ventricular dysfunction. SOLVD Investigators. JAMA 1993;270:1702-7. (Pubitemid 23295315)
8. Coats AJS, Adamopoulos S, Radaelli A, et al. Controlled trial of physical training in chronic heart failure. Exercise performance, hemodynamics, ventilation and autonomic function. Circulation 1992;85:2119-31.
9. Selig SE, Carey MF, Menzies DG, et al. Moderate-intensity resistance exercise training in patients with chronic heart failure improves strength, endurance, heart rate variability and forearm blood flow. J Card Fail 2004;10:21-30. (Pubitemid 38880888)
10. Myerson S, Hemingway H, Budget R, et al. Human angiotensin I-converting enzyme gene and endurance performance. J Appl Physiol 1999;87:1313-6. (Pubitemid 29483113)
11. Nazarov IB, Woods DR, Montgomery HE, et al. The angiotensin converting enzyme I/D polymorphism in Russian athletes. Eur J Hum Genet 2001;9:797-801. (Pubitemid 33014594)
12. Abraham MR, Olson LJ, Joyner MJ, et al. Angiotensin-converting enzyme genotype modulates pulmonary function and exercise capacity in treated patients with congestive stable heart failure. Circulation 2002;106:1794-9.
13. Rankinen T, Wolfarth B, Simoneau JA, et al. No association between the angiotensin-converting enzyme ID polymorphism and elite endurance athlete status. J Appl Physiol 2000;88:1571-5. (Pubitemid 30336903)
14. Cerit M, Colakoglu M, Erdogan M, Berdeli A, Cam FS. Relationship between ACE genotype and short duration aerobic performance development. Eur J Appl Physiol 2006;98:461-5. (Pubitemid 44873303)
15. Cam S, Colakoglu M, Colakoglu S, Sekuri C, Berdeli A. ACE I/D gene polymorphism and aerobic endurance development in response to training in a non-elite female cohort. J Sports Med Phys Fitness 2007;47:234-8.
16. Colakoglu M, Cam FS, Kayitken B, et al. ACE genotype may have an effect on single versus multiple set preferences in strength training. Eur J Appl Physiol 2005;95:20-6. (Pubitemid 43008892)
17. Folland J, Leach B, Little T, et al. Angiotensin-converting enzyme genotype affects the response of human skeletal muscle to functional overload. Exp Physiol 2000;85:575-9.
18. Defoor J, Vanhees L, Martens K, et al. The CAREGENE study: ACE gene I/D polymorphism and effect of physical training on aerobic power in coronary artery disease. Heart 2006;92:527-8.
19. Iwanaga Y, Nishi I, Ono K, et al. Angiotensin-converting enzyme genotype is not associated with exercise capacity or the training effect of cardiac rehabilitation in patients after acute myocardial infarction. Circ J 2005;69:1315-9. (Pubitemid 41560808)
20. Borg G. Perceived exertion: a note on history and methods. Med Sci Sports Exerc 1973;5:90-3.
21. Williams AD, Carey MF, Selig S, et al. Circuit resistance training in chronic heart failure improves skeletal muscle mitochondrial ATP production rate - a randomized controlled trial. J Card Fail 2007;13:79-85. (Pubitemid 46467392)
22. Williams AD, Selig S, Hare DL, et al. Reduced exercise tolerance in CHF may be related to factors other than impaired skeletal muscle oxidative capacity. J Card Fail 2004;10:141-8. (Pubitemid 38858075)
23. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988;16:1215.
24. Montgomery HE, Clarkson P, Dollery CM, et al. Association of angiotensin-converting enzyme gene I/D polymorphism with change in left ventricular mass in response to physical training. Circulation 1997;96:741-7. (Pubitemid 27329604)
25. Tyni-Lenne R, Dencker K, Gordon A, Jansson E, Sylven C. Comprehensive local muscle training increases aerobic working capacity and quality of life and decreases neurohormonal activation in patients with chronic heart failure. Eur J Heart Fail 2001;3:47-52. (Pubitemid 32127109)
26. Murphey LJ, Gainer JV, Vaughan DE, Brown NJ. Angiotensin-converting enzyme insertion/deletion polymorphism modulates the human in vivo metabolism of bradykinin. Circulation 2000;102:829-32.
27. Laughlin MH, Schrage WG, McAllister RM, Garverick HA, Jones AW. Interaction of gender and exercise training: vasomotor reactivity of porcine skeletal muscle arteries. J Appl Physiol 2001;90:216-27. (Pubitemid 32040951)
28. Westerkamp CM, Gordon SE. Angiotensin-converting enzyme inhibition attenuates myonuclear addition in overloaded slow-twitch skeletal muscle. Am J Physiol Regul Integr Comp Physiol 2005;289:R1223-31.
29. Gordon SE, Davis BS, Carlson CJ, Booth FW. ANG II is required for optimal overload-induced skeletal muscle hypertrophy. Am J Physiol Endocrinol Metab 2001;280:E150-9.
30. McNamara DM, Holubkov R, Postava L, et al. Pharmacogenetic interactions between angiotensin-converting enzyme inhibitor therapy and the angiotensin-converting enzyme deletion polymorphism in patients with congestive heart failure. J Am Coll Cardiol 2004;44:2019-26. (Pubitemid 39473288)
31. Coats AJ. Ethical authorship and publishing. Int J Cardiol 2009;131:149-50.